2010-33265. Manufacturer of Controlled Substances; Notice of Registration  

  • Start Preamble

    By Notice dated August 2, 2010, and published in the Federal Register on September 1, 2010, (75 FR 53721), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    DrugSchedule
    Amphetamine (1100)II
    Methamphetamine (1105)
    Lisdexamfetamine (1205)II
    Methylphenidate (1724)II
    Phenylacetone (8501)II
    Codeine (9050)II
    Oxycodone (9143)II
    Hydromorphone (9150)II
    Dextropropoxyphene, bulkII
    (non-dosage forms) (9273)
    Morphine (9300)II
    Thebaine (9333)II
    Raw Opium (9600)II
    Opium extracts (9610)II
    Opium, powdered (9639)II
    Opium, granulated (9640)II
    Poppy Straw (9650)II
    Oxymorphone (9652)II
    Concentrate of Poppy Straw (9670)II
    Sufentanil (9740)II
    Fentanyl (9801)II

    The company plans to manufacture the listed controlled substances in bulk for sale to its customers.

    No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex Charles City, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

    Start Signature

    Dated: December 23, 2010.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 2010-33265 Filed 1-4-11; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
01/05/2011
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
2010-33265
Pages:
587-587 (1 pages)
PDF File:
2010-33265.pdf